Identification and survival analysis of tTA/tetO-CCKR-2 double transgenic mice

doi:10.3969/j.issn.2095-4344.3079

Abstract

Abstract: BACKGROUND: The inducible forebrain-specific cholecystokinin receptor-2 (CCKR-2) double transgenic (tTA/tetO-CCKR-2 tg, abbreviated as dtg) mice are an ideal model of anxiety-related diseases. However, there is still a lack of model identification and life related data
OBJECTIVE: To identify the genomic DNA of the offspring and the specific expression of CCKR-2 transgene in the forebrain, and to analyze the survival probability of dtg mice.
METHODS: α-CaMKII/tTA single transgenic mice and tetO-CCKR-2 single transgenic mice were cross-fertilized to construct a dtg mouse model. The genomic DNA was extracted from the tail of the offspring, and the genotypes were detected by PCR and agarose gel electrophoresis. Wild-type (WT) mice were used as controls. In situ hybridization was used to detect the expression of CCKR-2. Survival of dtg mice and WT mice (30 females and 30 males) was observed and recorded within 2 years. The study protocol was approved by the Experimental Animal Ethics Committee of Southwest Medical University, with an approval No. 20150068.
RESULTS AND CONCLUSION: Agarose gel electrophoresis results showed the molecular weight of the PCR products of dtg mice was consistent with the expected target gene fragment. In situ hybridization results showed a strong signal of CCKR-2 was detected in the forebrain of dtg mice, but hardly present in the WT mice. The median survival time of dtg mice was 76 weeks in females and 77 weeks in males. The survival probability was decreased with age in dtg mice. The survival probability of WT mice was significantly better than that of dtg mice (P < 0.001). There was no significant sex difference between males and females of dtg mice (P=0.577). Therefore, the specific expression of CCKR-2 transgene in the forebrain can be identified using PCR amplification, genomic DNA extraction, agarose gel electrophoresis, and in situ hybridization. tTA/tetO-CCKR-2 double transgenic induction may shorten the survival time of mice, but no significant difference is observed between the females and males of dtg mice.

Key words: double transgenic mouse">, genotype identification">, in situ hybridization">, survival analysis">, anxiety disorder">, fear behavior">, post-traumatic stress disorder

CLC Number:

Gao Ziqing, Ruan Sibei, Li Li, Ling Feng, Tang Xiaoqin, Kang Qingmei, Luo Siyi, Luo Jing, Tang Yaping, Tang Mingxi . Identification and survival analysis of tTA/tetO-CCKR-2 double transgenic mice[J]. Chinese Journal of Tissue Engineering Research, 2021, 25(11): 1682-1687.

Figures/Tables 10

References

[1] Ma H, Miller C. Trapped in a Double Bind: Chinese Overseas Student Anxiety during the COVID-19 Pandemic.Health Commun. 2020;12:1-8.
[2] Eskander N, Vadukapuram R, Zahid S, et al. Post-traumatic Stress Disorder and Suicidal Behaviors in American Adolescents: Analysis of 159,500 Psychiatric Hospitalizations. Cureus. 2020;12:e8017.
[3] McNeill RV, Ziegler GC, Radtke F, et al. Mental health dished up-the use of iPSC models in neuropsychiatric research. J Neural Transm (Vienna). 2020 May 7. doi: 10.1007/s00702-020-02197-9.
[4] BALLAZ SJ, BOURIN M, AKIL H, et al. Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109761.
[5] ROCA-LAPIROT O, FOSSAT P, MA S, et al. Acquisition of analgesic properties by the cholecystokinin (CCK)/CCK2 receptor system within the amygdala in a persistent inflammatory pain condition. Pain. 2019; 160: 345-357.
[6] 姜云璐,王正文,陈京,等.胆囊收缩素Ⅱ型受体研究进展[J].济宁医学院学报,2018,41(3):199-203.
[7] RATAUD J, DARCHE F, PIOT O, et al. Anxiolytic effect of CCK-antagonists on plus-maze behavior in mice．Brain Res. 1991;48(1-2):315-317.
[8] CHEN Q, NAKAJIMA A, MEACHAM C, et al. Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse. Proc Natl Acad Sci U S A. 2006; 103(10):3881-3886.
[9] CHEN Q, TANG M, MAMIYA T, et al. Bi-Directional effect of cholecystokinin receptor-2 overexpression on Stress-Triggered fear memory and anxiety in the mouse. PLoS One. 2010;5(12):e15999.
[10] MARIAM H, LAUREN BS. Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020;44:102261.
[11] BUNEVICIUS A, DELTUVA VP, TAMASAUSKAS A. Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study.Oncotarget. 2017;8:57543-57551.
[12] DING T, WANG X, FU A, et al. Anxiety and depression predict unfavorable survival in acute myeloid leukemia patients.Medicine (Baltimore). 2019;98:e17314.
[13] AMY M, JANE W, STEPHEN P, et al. Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.Lancet Psychiatry. 2018;5(4):321-326.
[14] 石宏,何伟,王晓宇,等.TRPV1和ASIC3基因敲除小鼠的寿命观察[J].中国比较医学杂志,2014,24(10):79-89.
[15] 唐红,唐晓琴,邓飞,等.presenilin-1/presenilin-2双基因敲除小鼠的寿命观察[J].中国比较医学杂志,2016,26(11):6-10.
[16] ZWANZGER P, DOMSCHKE K, BRADWEJN J, et al. Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. Depress Anxiety. 2012;29(9):762-774.
[17] ZHANG JF, CHEN L, ZHANG J, et al. Drug Inducible CRISPR/Cas Systems.Comput Struct Biotechnol J. 2019;17:1171-1177.
[18] BAI Y, ZHU C, FENG M, et al. Establishment of A Reversibly Inducible Porcine Granulosa Cell Line.Cells.2020; 9:156.
[19] 张文将,易健,贾平,等.载脂蛋白E基因敲除(APOE-/-)小鼠基因的鉴定方法及模型应用[J].中国组织工程研究,2019,23(7): 1103-1108.
[20] JIANG H, LIU X, LI Q. Application of transgenic animal models in colorectal cancer research.World Chin J Digest. 2015;23(10):1603-1608.
[21] GERBER SD, BEAUCHAMP P, ZHUANG L, et al. Functional domains of the FgfrL1 receptor. Developmental biology. 2020;461(1): 43-54.
[22] MARCHESE M, COWAN D, HEAD E, et al. Autoimmune manifestations in the 3xTg-AD model of Alzheimer’s disease. J Alzheimers Dis. 2014; 39(1):191-210.
[23] RAE EA, BROWN RE. The problem of genotype and sex differences in life expectancy in transgenic AD mice. Neurosci Biobehav Rev. 2015; 57:238-251.
[24] BOGUE MA, PETERS LL, PAIGEN B, et al. Accessing Data Resources in the Mouse Phenome Database for Genetic Analysis of Murine Life Span and Health Span. J Gerontol A Biol Sci Med Sci. 2016;71(2):170-177.
[25] PUGH PL, RICHARDSON JC, BATE ST, et al. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer’s disease.Behav Brain Res. 2007;178(1):18-28.